Brief: Xspray Q4 Revenue SEK 0

Xspray Pharma publ AB

12/02/2026 07:00

Feb 12 (Reuters) - Xspray Q4 pretax profit SEK -37.009 million.

Q4 adjusted EPS SEK -0.89

Q4 adjusted free cash flow SEK -41.37 million